RadNet RDNT
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
About
RadNet (RDNT) Business Model and Operations Summary
RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments: Imaging Center segment and Digital Health segment. The Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), and fluoroscopy. The Digital Health segment develops and deploys clinical applications to enhance the interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics.
Key Insights
RadNet (RDNT) Core Market Data and Business Metrics
Latest Closing Price
$50.62Market Cap
$3.76 BillionPrice-Earnings Ratio
-723.14Total Outstanding Shares
74.04 Million SharesTotal Employees
11,021Dividend
No dividendIPO Date
January 3, 1997SIC Description
Services-medical LaboratoriesPrimary Exchange
NASDAQHeadquarters
1510 Cotner Ave, Los Angeles, CA, 90025
Historical Stock Splits
| Execution Date | Split Amount |
|---|---|
| No Historical Stock Splits | |
Cash Flow Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Exchange Gains/Losses | $-81,000 |
| Net Cash Flow From Operating Activities, Continuing | $279.41 Million |
| Net Cash Flow From Investing Activities | $-232.90 Million |
| Net Cash Flow From Operating Activities | $279.41 Million |
| Net Cash Flow, Continuing | $411.11 Million |
| Net Cash Flow From Financing Activities, Continuing | $364.60 Million |
Income Statement
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Income Tax Expense/Benefit | $5.66 Million |
| Net Income/Loss Attributable To Noncontrolling Interest | $35.02 Million |
| Net Income/Loss Available To Common Stockholders, Basic | $-4.41 Million |
| Nonoperating Income/Loss | $-68.16 Million |
| Income/Loss From Continuing Operations Before Tax | $36.27 Million |
| Income/Loss From Equity Method Investments | $13.80 Million |
Comprehensive Income
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Other Comprehensive Income/Loss | $16.45 Million |
| Comprehensive Income/Loss | $47.06 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $35.02 Million |
| Comprehensive Income/Loss Attributable To Parent | $12.04 Million |
Balance Sheet
October 1, 2023 to September 30, 2024
| Metric | Value |
|---|---|
| Equity | $1.12 Billion |
| Other Non-current Liabilities | $665.93 Million |
| Fixed Assets | $663.87 Million |
| Long-term Debt | $1.02 Billion |
| Liabilities And Equity | $3.28 Billion |
| Equity Attributable To Parent | $895.31 Million |
Historical Dividends
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| No historical dividends | ||||